Synthetic peptidoglycans mediate fibrillogenesis to resolve the trade-off between manufacturing simplicity and precise structural control in tissue engineering.
Skin-derived fibroblasts express tendon markers to regenerate injured tissue, avoiding invasive autologous cell collection.
Modifying enzyme volume prevents excessive crosslinking and reduces diffusion, maintaining stable hydrogel mechanical properties.
N-hydroxysuccinimide ester modification and binding agent extraction remove endotoxins from gelatin, avoiding lengthy dialysis.
Trans-splicing molecules correct genetic defects by forming chimeric RNA, avoiding insertional mutagenesis risks.
Arginine and polysorbate 20 prevent precipitation, enabling high-concentration formulations that restore skin integrity in dystrophic epidermolysis bullosa.
Lens capsule extraction avoids enzymatic degradation to yield high-purity collagen with intact functional domains.
Targeted genome editing corrects USH2A mutations while bypassing adeno-associated virus size limits.
Segmenting the LG3 domain isolates a soluble peptide that demonstrates cell adhesion without complex protein expression.